{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-23-002176","form_type":"8-K","ticker":"ENTXW","cik":"0001638097","company_name":"Entera Bio Ltd.","filed_at":"2023-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.779288+00:00","generated_at":"2026-06-14T05:52:27.289615+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Entera Bio appoints Haya Taitel to Board of Directors, Class II","bullets":["Board expanded Class II from one to two directors; Taitel appointed June 4, 2023, term through 2025 annual meeting.","Taitel is Head of Sanofi's Global Transplant Franchise; previously Kadmon CCO (Rezurock launch) and Johnson & Johnson leader.","Board determined Taitel independent under SEC and Nasdaq rules; no material transactions with company.","Taitel to receive standard non-employee director compensation (cash retainers + annual option grants under 2018 plan)."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-23-002176","json":"https://secwatch.observer/filing/0001178913-23-002176.json","markdown":"https://secwatch.observer/filing/0001178913-23-002176.md","text":"https://secwatch.observer/filing/0001178913-23-002176.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638097/000117891323002176/0001178913-23-002176-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638097/000117891323002176/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T05:52:27.289615+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"637d407a62","claim":"Haya Taitel was appointed as Director at Entera Bio Ltd..","evidence_excerpt":"On June 4, 2023, the Board of Directors (the “ Board ”) of Entera Bio Ltd., a company organized under the laws of the State of Israel (the “ Company ”), expanded Class II of the Board from one to two directors and appointed Ms. Haya Taitel to fill the resulting vacancy.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891323002176/0001178913-23-002176-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}